Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
View/ Open
Date
2021-10-27ICR Author
Author
Fendler, A
Shepherd, STC
Au, L
Wilkinson, KA
Wu, M
Byrne, F
Cerrone, M
Schmitt, AM
Joharatnam-Hogan, N
Shum, B
Tippu, Z
Rzeniewicz, K
Boos, LA
Harvey, R
Carlyle, E
Edmonds, K
Del Rosario, L
Sarker, S
Lingard, K
Mangwende, M
Holt, L
Ahmod, H
Korteweg, J
Foley, T
Bazin, J
Gordon, W
Barber, T
Emslie-Henry, A
Xie, W
Gerard, CL
Deng, D
Wall, EC
Agua-Doce, A
Namjou, S
Caidan, S
Gavrielides, M
MacRae, J
Kelly, G
Peat, K
Kelly, D
Murra, A
Kelly, K
O'Flaherty, M
Dowdie, L
Ash, N
Gronthoud, F
Shea, RL
Gardner, G
Murray, D
Kinnaird, F
Cui, W
Pascual, J
Rodney, S
Mencel, J
Curtis, O
Stephenson, C
Robinson, A
Oza, B
Farag, S
Leslie, I
Rogiers, A
Iyengar, S
Ethell, M
Messiou, C
Cunningham, D
Chau, I
Starling, N
Turner, N
Welsh, L
van As, N
Jones, RL
Droney, J
Banerjee, S
Tatham, KC
O'Brien, M
Harrington, K
Bhide, S
Okines, A
Reid, A
Young, K
Furness, AJS
Pickering, L
Swanton, C
Gandhi, S
Gamblin, S
Bauer, DL
Kassiotis, G
Kumar, S
Yousaf, N
Jhanji, S
Nicholson, E
Howell, M
Walker, S
Wilkinson, RJ
Larkin, J
Turajlic, S
Type
Journal Article
Metadata
Show full item recordSubject
Science & Technology
Life Sciences & Biomedicine
Oncology
COVID-19 VACCINATION
IMMUNOGENICITY
MALIGNANCIES
DEMOGRAPHICS
VACCINES
Research team
Molecular Oncology
Gastrointestinal Cancers Clinical Trials
Medicine (RMH Smith Cunningham)
Melanoma and Kidney Cancer
Treatment of thoracic tumours
Targeted Therapy
Language
eng
Date accepted
2021-10-27
License start date
2021-10-27
Citation
NATURE CANCER, 2021, pp. ? - ? (31)
Publisher
NATURE PORTFOLIO